Cargando…
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
There are few prognostic biomarkers and targeted therapeutics currently in use for the clinical management of oral squamous cell carcinoma (OSCC) and patient outcomes remain poor in this disease. A majority of mutations in OSCC are loss-of-function events in tumour suppressor genes that are refracto...
Autores principales: | Arora, Rahul, Haynes, Logan, Kumar, Mehul, McNeil, Reid, Ashkani, Jahanshah, Nakoneshny, Steven C., Matthews, T. Wayne, Chandarana, Shamir, Hart, Robert D., Jones, Steven J. M., Dort, Joseph C., Itani, Doha, Chanda, Ayan, Bose, Pinaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191846/ https://www.ncbi.nlm.nih.gov/pubmed/36635327 http://dx.doi.org/10.1038/s41417-022-00578-8 |
Ejemplares similares
-
Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response
por: Arora, Rohit, et al.
Publicado: (2023) -
Efficacy of postoperative pain management in head and neck cancer patients
por: Hinther, Ashley, et al.
Publicado: (2018) -
Chronic opioid use following surgery for head and neck cancer patients undergoing free flap reconstruction
por: Hinther, Ashley, et al.
Publicado: (2021) -
The impact of close surgical margins on recurrence in oral squamous cell carcinoma
por: Solomon, Joseph, et al.
Publicado: (2021) -
Harmonic scalpel impact on blood loss and operating time in major head and neck surgery: a randomized clinical trial
por: Fritz, Dieter K., et al.
Publicado: (2016)